StockWatch
·
Pharmaceuticals
Tax & Penalty29 Jul 2026, 12:31 pm

Zydus Lifesciences Faces ₹108.54M Stamp Duty Demand

AI Summary

Zydus Lifesciences Ltd has received an order from the Office of the Superintendent of Stamps, Gandhinagar, Gujarat, concerning a Sale Deed for asset acquisition from Sterling Biotech Limited. The authority determined a higher market value for the transferred assets, leading to a demand for additional stamp duty and penalties. The total demand amounts to ₹108.54 million, comprising ₹53.47 million in alleged deficient stamp duty and ₹55.07 million in penalties. The company is currently evaluating the order and exploring available legal remedies.

Key Highlights

  • Stamp duty authority demands ₹108.54 million from Zydus Lifesciences.
  • Demand includes ₹53.47 million in alleged deficient stamp duty.
  • Penalties totaling ₹55.07 million have also been levied.
  • Order relates to asset acquisition from Sterling Biotech Limited.
  • Company is assessing legal options and remedies.